Intramuscular Transplantation of Allogeneic Mesenchymal Stromal Cells Derived from Equine Umbilical Cord.
- Author:
Marianne Camargos DIAS
1
;
Fernanda DA CRUZ LANDIM-ALVARENGA
;
Carolina Nogueira DE MORAES
;
Leonardo Dourado DA COSTA
;
Caroline Medeiros GERALDINI
;
Vânia Maria DE VASCONCELOS MACHADO
;
Leandro MAIA
Author Information
- Publication Type:Original Article
- Keywords: Mesenchymal stromal cells; Allogeneic; Transplantation; Muscle; Umbilical cord
- MeSH: Biopsy; Immunomodulation; Inflammation; Mesenchymal Stromal Cells*; Stem Cells; Transplantation; Ultrasonography; Umbilical Cord*
- From:International Journal of Stem Cells 2016;9(2):239-249
- CountryRepublic of Korea
- Language:English
- Abstract: BACKGROUND AND OBJECTIVES: Mesenchymal stromal cells (MSCs) have great therapeutic potential, particularly in the process of tissue repair and immunomodulation through the secretion of biomolecules. Thus, the aim of this study was to evaluate the hypothesis that intramuscular transplantation of allogeneic MSCs obtained from equine umbilical cord (UC-MSCs) is safe, demonstrating that this is a suitable source of stem cells for therapeutic use. METHODS AND RESULTS: For this, UC-MSCs were cultured, characterized and cryopreserved for future transplantation in six healthy mares. On day 0, transplantation of three million UC-MSCs diluted in Hank’s Balanced Solution (HBSS) was performed on right and left sides of the rump muscle. As a control, HBSS injections were performed caudally in the same muscle. Muscle biopsies were obtained as a control 30 days before transplantation (D-30). The biopsies were collected again on day 2 (left side) and day 7 (right side) post transplantation and examined histologically. All procedures were preceded by ultrasound examination and blood sampling. Hematologic evaluation remained within normal limits and no differences were observed between time points (p>0.05). Ultrasound examination was suggestive of inflammation 48 hours after transplantation in both groups (control and treated). At histological evaluation it was found only discrete inflammation signals between D-30×D2 (p<0.05) in the treated group, without differences (p> 0.05) between the groups at different time points. CONCLUSIONS: Equine UC-MSCs under the experimental conditions did not promote severe inflammation that causes tissue damage or lead to its rejection by the host organism and therefore has a good potential for clinical use.
